Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S47, 2018. DOI: 10.25251/skin.2.supp.47. Disponível em: https://skin.dermsquared.com/skin/article/view/303. Acesso em: 19 apr. 2025.